Anda di halaman 1dari 18

Chemical (Alkali and Acid) Injury of the

Conjunctiva and Cornea


Original article contributed by: Danielle Trief, MD, James Chodosh MD, Kathryn Colby MD
All contributors:
Danielle Trief, MD, Dylan Griffiths and WikiWorks Team
Assigned editor:
Chemical (alkali and acid) injury of the conjunctiva and cornea is a true ocular emergency and
requires immediate intervention. Chemical injuries to the eye can produce extensive damage to the
ocular surface and anterior segment leading to visual impairment and disfigurement. Early
recognition and treatment ensures the best possible outcome for this potentially blinding condition.

Contents
[hide]
1 Disease Entity

1.1 International Classification of Diseases

1.2 Epidemiology

1.3 Etiology

1.4 Pathophysiology

1.4.1 Alkali

1.4.2 Acids
1.5 Primary prevention
2 Diagnosis

2.1 History

2.2 Physical examination

2.3 Symptoms

3 Management

3.1 Irrigation

3.2 Medical therapy

3.2.1 Standard Treatments

3.2.2 Other Treatments:

3.3 Surgical Treatments

3.4 Recommended Treatment

3.4.1 Grade I

3.4.2 Grade II

3.4.3 Grade III

3.4.4 Grade IV

3.5 Stages of Ocular Recovery

3.6 Follow up

3.7 Other long term complications

3.7.1 Glaucoma

3.7.2 Dry eye

3.7.3 Damage to the eyelids or palpebral conjunctiva

4 Additional Resources

5 References

Disease Entity[edit source]

International Classification of Diseases[edit source]


ICD-9-CM 940.2 alkaline chemical burn to cornea and conjunctiva, 940.3 acid chemical burn to the
cornea and conjunctiva, 372.06 chemical conjunctivitis
ICD-10-CM T26.60XA Corrosion of cornea and conjunctival sac, unspecified eye, initial encounter.

Epidemiology[edit source]
Chemical injuries to the eye represent between 11.5%-22.1% of ocular traumas. [1]About two thirds of
these injuries occur in young men. The vast majority occur in the workplace as a result of industrial
accidents. A minority of injuries occur in the home or secondary to assault. Alkali materials are found
more commonly in building materials and cleaning agents and occur more frequently than acid
injuries.[2]

Etiology[edit source]
Chemical injuries occur as a result of acid, alkali, or neurtral agents. Common causes of alkali and
acid injuries are listed below.[2][3]

Pathophysiology[edit source]
Alkali[edit source]
Alkali agents are lipophilic and therefore penetrate tissues more rapidly than acids.
They saponify the fatty acids of cell cell membranes, penetrate the corneal stroma and

destroyproteoglycan ground substance and collagen bundles. The damaged tissues then
secrete proteolytic enzymes, which lead to further damage.[4][5]

Acids[edit source]
Acids are generally less harmful than alkali substances. They cause damage
by denaturing and precipitating proteins in the tissues they contact. The coagulated proteins act as a
barrier to prevent further penetration (unlike alkali injuries). [5] The one exception to this
is hydrofluoric acid, where the fluoride ion rapidly penetrates the thickness of the cornea and causes
significant anterior segment destruction.[6]

Primary prevention[edit source]


Since the majority of injuries occur at work, protective eye shields are mandatory when handling
potentially corrosive substances (OSHA regulation, 1910.133). However, even protective goggles are
no match for chemicals under high pressure.

Diagnosis
[edit source]

History[edit source]
The severity of ocular injury depends on four factors: the toxicity of the chemical, how long the
chemical is in contact with the eye, the depth of penetration, and the area of involvement. It is
therefore critical to take a careful history to document these factors. The patient should be asked
when the injury occurred, whether they rinsed their eyes afterwards and for how long, the
mechanism of injury (was the chemical under high pressure?), the type of chemical that splashed in
the eye, and whether or not they were wearing eye protection. If available, it is helpful to obtain the
packaging of the chemical. There is often product information on this packaging including chemical
composition. If this information is not immediately available, chemical information can be found by
contacting the local poison control center at aapcc or 1 800-222-1222.

Physical examination[edit source]


Prior to a full ophthalmic exam, the pH of both eyes should be checked. If the pH is not in physiologic
range, then the eye must be irrigated to bring the pH to an appropriate range (between 7 and 7.2). It
is recommended to wait at least five minutes after irrigation before checking the pH to ensure that
the pH does not rise or fall secondary to retained particulate matter.
The physical exam should be used to assess the extent and depth of injury (see classification

schemes below). Specifically, the degree of corneal, conjunctival and limbalinvolvement should be
documented, as it can be used to predict ultimate visual outcome.[7]
The palpebral fissures should be checked and the fornices should be swept during the initial exam.
Both the palpebral and bulbar conjunctiva should be examined with fluoresceinunder a cobalt blue
light. As above, retained particulate matter can cause persistent damage, despite irrigation.
The intraocular pressure should also be documented, as alkali injuries have been found to both
acutely and chronically cause an elevation of IOP.[8]
Two major classification schemes for corneal burns are the Roper-Hall (modified Hughes)
classification[9][10] and the Dua classification.[11] The Roper-Hall classification is based on the degree of
corneal involvement and limbal ischemia. The Dua classification is based on an estimate of limbal
involvement (in clock hours) and the percentage of conjunctival involvement. In a randomized
controlled trial of acute burns, the Dua classification was found to be superior to the Roper-Hall in
predicting outcome in severe burns.[7] However, both classification schemes are commonly employed
in daily practice.

Symptoms[edit source]
The most common symptoms are severe pain, epiphora, blepharospasm, and reduced visual acuity.

Management
[edit source]

Irrigation[edit source]

Early irrigation is critical in limiting the duration of chemical exposure. The goal of irrigation is to
remove the offending substance and restore the physiologic pH. It may be necessary to irrigate as
much as 20 liters to achieve this. To optimize patient comfort and ensure effective delivery of the
irrigating solution, a topical anesthetic is generally administered. An eyelid speculum or Morgan
Lens (MorTan, Missoula MT) can be used to keep the eye open, while the irrigating solution is
delivered through IV tubing. There has been some debate on the most effective irrigating solutions. A
study by Herr et al. compared Normal Saline (NS), Normal Saline with Bicarbonate (NS +
Bicarb),Lactated Ringers solution (LR), and Balanced Saline Solution Plus (BSS Plus, Alcon
Laboratories, Fort Worth, TX) irrigating solutions to investigate which solution optimized patient
comfort. They found that patients tolerated and preferred BSS irrigation compared to NS, NS +
Bicarb, and LR.[12] In experiments in rabbit eyes following sodium hydroxide injury, a borate buffer
solution called Cedderroth eye wash(Cedderroth Industrial Products, Upplands Vaasby Sweden) and
a Diphthorine and Previn solution (Prevor, Cologne Germany) more efficiently normalized the pH
compared to saline and phosphate buffer solutions.[13] Of course, early irrigation is paramount to

limiting the duration of chemical exposure. If clean water is available at the site of injury and a
standard irrigating solution is not, then the eyes should immediately be washed out with water. [14][15]

Medical therapy[edit source]


Patients with mild to moderate injury (Grade I and II) have a good prognosis and can often be treated
successfully with medical treatment alone. The aims of medical treatment are to enhance recovery of
the corneal epithelium and augment collagen synthesis, while also minimizing collagen breakdown
and controlling inflammation.[3]

Standard Treatments[edit source]


Antibiotics- A topical antibiotic ointment like erythromycin ointment four times daily can be used to
provide ocular lubrication and prevent superinfection. Stronger antibiotics (e.g. a
topical fluoroquinolone) are employed for more severe injuries (e.g. Grade II and above).
Cycloplegic agents such as atropine or cyclopentolate can help with comfort.
Artificial tears- and other lubricating eye drops, preferably preservative free, should be used
generously for comfort.
Steroid drops- In the first week following injury, topical steroids can help calm inflammation and
prevent further corneal breakdown.[14] In mild injuries, topical prednisolone(Predforte) can be
employed four times daily. In more severe injuries, prednisolone can be used every hour. After about
one week of intensive steroid use, the steroids should be tapered because the balance of collagen
synthesis vs. collagen breakdown may tip unfavorably toward collagen breakdown. [16]

Other Treatments:[edit source]


Ascorbic acid- is a cofactor in collagen synthesis and may be depleted following chemical
injury. Ascorbic acid can be used as a topical drop (10% every hour) or orally (two grams, four times
daily in adults). In one study, severe alkali burns in rabbit eyes were associated with reduced
ascorbic acid levels in the aqueous humor. This reduction correlated with corneal stromal ulceration
and perforation. Systemic administration of Vitamin C helped promote collagen synthesis and reduce
the level of ulceration.[17]Care must be taken in patients with compromised renal function because
high levels of Vitamin C are potentially toxic to the kidneys.[18]
Doxycycline- acts independently of its antimicrobial properties to reduce the effects of matrix
metalloproteinases (MMPs), which can degrade type I collagen. The tetracyclineclass inhibits MMPs
by restriction of the gene expression of neutrophil collagenase and epithelial gelatinase, suppression
of alpha 1 antitrypsin degradation and scavenging reactive oxygen species, thereby reducing ocular
surface inflammation.[19][20]
Citrate drops- histological sections of cornea from alkali burns reveal an intense polymorphonuclear
infiltrate (PMN).[21] PMNs provide a major source of proteolytic enzymes, which can dissolve the
corneal stromal collagen. Deficiency in calcium inhibits the PMNs from granulating and releasing

proteolytic enzymes. Citrate is a potent chelator and can therefore decrease proteolytic activity.
Citrate also appears to inhibit collagenases.[22][23]
1% Medroxyprogesterone- is a progestational steroid and has less anti-inflammatory potency than
corticosteroids, but has a minimum effect on stromal repair.Medroxyprogesterone can therefore be
substituted for cortical steroids after 10-14 days of steroid treatment. [2][24]
Platelet rich plasma eye drops- have been found to be rich in growth factors and platelet rich
plasma eye drops can lead to faster epithelialization for certain classes of burns.[25]

Surgical Treatments[edit source]


Debridement of necrotic epithelium- should be performed as early as possible
because necrotic tissue serves as a source of inflammation and can inhibit epithelialization. [3]
Conjunctival/Tenons transposition (Tenonplasty)- in Grade IV burns, anterior segment necrosis can
result from loss of limbal vascular blood supply. In severe limbal ischemia, a sterile corneal ulceration
can ensue. After removal of necrotic tissue, a tenonplasty (advancement of the conjunctiva and
Tenons to the limbus) can be employed to reestablish limbal vascularity and facilitate reepithelialization.[26]

Amniotic membrane transplantation (AMT)- the purpose of AMT is to rapidly restore the
conjunctival surface and to reduce limbal and stromal inflammation. The benefits are thought to be
two fold: physical and biological. Physically, AMT has been shown to improve patient comfort by
reduction of eyelid friction. Numerous studies have found a reduction in pain following AMT for
moderate to severe burns.[27][28] Through its physical actions, AMT may also
prevent symblepharon formation. Amniotic membrane is also felt to have biologic effects. [29] It
expresses TGFB1 and epidermal growth factor, which have roles in wound healing.[30][31] It has also
been found to have anti-inflammatory properties.[32][33][34] Taken together, these biological effects may
dampen inflammation, promote epithelial growth, prevent scarring and prevent neovascularization.
New delivery devices like ProKera (Bio-Tissue, Miami, Florida), which consists of a piece

of cryopreserved amniotic membrane clipped into a dual ring system, like a symblepharon ring,
allows rapid and sutureless placement of amniotic membrane.[35] A recent Cochrane review found
only one randomized controlled trial of amniotic membrane for treatment of chemical ocular burn in
the first seven days following injury.[1]Patients with moderate burns were found to have a significantly
better visual acuity following AMT compared to medical therapy alone.[36] However, this was an
unmasked trial and there were uneven baseline characteristics of the control and treatment eyes.
[1]
While case series and reviews show great promise of AMT in the treatment of chemical burns,
conclusive evidence is still lacking.
Limbal stem cell transplant- Much of the damage following chemical injuries results from limbal
ischemia and the subsequent loss of stem cells capable of repopulating the corneal
epithelium. Limbal stem cell transplants have been employed to replace this critical group of cells.
Limbal stem cells are located at the base of the limbal epithelium and are responsible for
repopulation of cells in the corneal epithelium and inhibition of conjunctival growth over the cornea.
[37]
Limbal autografts can be used from the healthy contralateral eye if only one eye is injured in a
chemical burn.[38] When both eyes are injured, transplants have been attempted from living related
donors. In a recent study from China, a portion of the limbus of HLA matched living related
donors (allograft) was transplanted following chemical injury. Patients experienced a reduction in
vascularity, improved corneal opacity and corneal epithelialization without the need for systemic
immunosuppression.[37] Another option is to use cadaveric donors. This requires systemic
immunosuppression.[39] When possible, limbal stem cell transplantation should be delayed until ocular
surface inflammation has quieted.[40][41]
Cultivated oral mucosal epithelial transplantation (COMET)- can also be used to promote reepithelialization and reduce inflammation in corneal burns. The cells are harvested from the patients
own buccal mucosa so that systemic immunosuppression is not necessary.[42][43]
Boston Keratoprosthesis- Severe chemical injury leads to chronic inflammation and scarring,
making visual recovery challenging. In cases with severe inflammation, limbal stem cell transplants
and corneal transplants do not survive. In these most difficult cases, the Boston
Keratoprosthesis can be used. Because it is independent of stem cell function, it does not require
systemic immunosuppression.[44]

Recommended Treatment[edit source]


While there is variability in treatment strategies of chemical burns, most authors recommended a
graded approach depending on the severity of injury. Mild burns (Roper-Hall grade I) respond well to
medical treatments and lubrication, while more severe burns necessitate more intensive medical
therapies and surgery. Below is a paradigm for the initial treatment of chemical injury based on the
Roper-Hall grade of injury.[3][45]

Grade I[edit source]

Topical antibiotic ointment (erythromycin ointment or similar) four times a day

Prednisolone acetate 1% four times a day

Preservative free artificial tears as needed

If there is pain, consider a short acting cycloplegic like cyclopentolate three times a day

Grade II[edit source]

Topical antibiotic drop like fluoroquinolone four times daily


Prednisolone acetate 1% hourly while awake for the first 7-10 days. Consider tapering the
steroid if the epithelium has not healed by day 10-14. If an epithelial defect persists after day 10,
consider progestational steroids (1% medroxyprogesterone four times daily)

Long acting cycloplegic like atropine

Oral Vitamin C, 2 grams four times a day

Doxycycline, 100 mg twice a day (avoid in children)

Sodium ascorbate drops (10%) hourly while awake

Preservative free artificial tears as needed

Debridement of necrotic epithelium and application of tissue adhesive as needed

Grade III[edit source]

As for Grade II
Consider amniotic membrane transplant/Prokera placement. This should ideally be
performed in the first week of injury

Grade IV[edit source]

As for Grade II/III


Early surgery is usually necessary. For significant necrosis, a Tenonplasty can help
reestablish limbal vascularity. An amniotic membrane transplant is often necessary due to the
severity of the ocular surface damage.

Stages of Ocular Recovery[edit source]


Stages of ocular recovery following chemical injury- [3][6]

Figure E

Figure F

*Images courtesy of Dr. Kathryn Colby (Massachusetts Eye and Ear Infirmary)

Follow up[edit source]


With severe chemical burns, patients should initially be followed daily. If there is concern for
compliance with medication or if the patient is a child, one should consider inpatient admission.
Once the health of the ocular surface has been restored, follow up can be spread apart. However,

even in the healthiest appearing eyes, patients need long term monitoring for glaucoma and dry
eye as below.

Other long term complications[edit source]


Glaucoma[edit source]
Glaucoma is quite common following ocular injury, ranging in frequency from 15%-55% in patients
with severe burns.[8] The mechanism of glaucoma is multifactorial and includes contraction of the
anterior structures of the globe secondary to chemical and inflammatory damage, inflammatory
debris in the trabecular meshwork, and damage to the trabecular meshwork itself.[46] More severe
burns (Roper-Hall Grade III or IV) have been found to have significantly higher intraocular pressure
at presentation and were more likely to require long term glaucoma medication and undergo
glaucoma surgery than grade I or II injuries.[8] Glaucoma medications should be prescribed as
necessary to maintain normal intraocular pressure

Dry eye[edit source]


Chemical injury can destroy conjunctival goblet cells, leading to a reduction or even absence of
mucus in the tear film, and compromising the proper dispersion of the precorneal tear film. This
mucus deficiency results in keratoconjunctivitis sicca (dry eye). [47] Even in well-healed eyes, chronic
dry eye can cause significant morbidity because of discomfort, visual disturbance, and potential for
damage of the ocular surface.

Damage to the eyelids or palpebral conjunctiva[edit source]


Direct chemical damage to the conjunctiva can lead to scarring, forniceal shortening, symblepharon
formation and ciccatricial entropion or ectropion. These entities are encountered weeks to months
after injury and can be treated by suppressing inflammation and with early amniotic membrane
transplantation or oral mucosal graft.[3][48][49]

Additional Resources[edit source]


American Academy of Ophthalmology: http://www.aao.org
American Association of Poison Control Centers: http://www.aapcc.org (1-800-222-1222)
Iowa State Universitys Chemistry Material Safety Data
Sheets: http://avogadro.chem.iastate.edu/MSDS/
Occupational Safety and Health Administration requirement for eye protection at work:
http://www.osha.gov/pls/oshaweb/owadisp.show_document?p_table=STANDARDS&p_id=9778

Amniograft & Prokera: http://www.biotissue.com/

References[edit source]
1.

Jump up to:1.0 1.1 1.2 Clare, G., et al., Amniotic membrane transplantation for acute ocular burns.
Cochrane database of systematic reviews, 2012. 9: p. CD009379.

2.

Jump up to:2.0 2.1 2.2 Wagoner, M.D., Chemical injuries of the eye: current concepts in
pathophysiology and therapy. Survey of ophthalmology, 1997. 41(4): p. 275-313.

3.

Jump up to:3.0 3.1 3.2 3.3 3.4 3.5 Colby, K., Chemical injuries of the Cornea. Focal Points in American
Academy of Ophthalmology.2010. 28(1): p. 1-14.

4.

Jump up Fish, R. and R.S. Davidson, Management of ocular thermal and chemical injuries,
including amniotic membrane therapy. Current opinion in ophthalmology, 2010. 21(4): p. 31721.

5.

Jump up to:5.0 5.1 Barouch F, Colby KA. Evaluation and initial management of patients with ocular
and adnexal trauma. In: Miller JW, Azar DT, Blodi B eds. Albert and Jakobiec's Principles and
Practice of Ophthalmology, 3rd ed. Philadelphia: WB Saunders Elsevier: 2008: 5071-5092.

6.

Jump up to:6.0 6.1 McCulley, J., Chemical Injuries. 2 ed. The Cornea: Scientific Foundation and
Clinical Practice, ed. S.G.a.T. RA1987, Boston: Little, Brown and Co.

7.

Jump up to:7.0 7.1 Gupta, N., M. Kalaivani, and R. Tandon, Comparison of prognostic value of Roper
Hall and Dua classification systems in acute ocular burns. The British journal of ophthalmology,
2011. 95(2): p. 194-8

8.

Jump up to:8.0 8.1 8.2 Lin, M.P., et al., Glaucoma in patients with ocular chemical burns. American
journal of ophthalmology, 2012. 154(3): p. 481-485 e1.

9.

Jump up Hughes, W., Alkali burns of the eye. I. Review of the literature and summary of
present knowledge. Archives of ophthalmology, 1946. 35: p. 423.

10.

Jump up Roper-Hall, M.J., Thermal and chemical burns. Transactions of the


ophthalmological societies of the United Kingdom, 1965. 85: p. 631-53.

11.

Jump up Dua, H.S., A.J. King, and A. Joseph, A new classification of ocular surface burns.
The British journal of ophthalmology, 2001. 85(11): p. 1379-83.

12.

Jump up Herr, R.D., et al., Clinical comparison of ocular irrigation fluids following chemical
injury. The American journal of emergency medicine, 1991. 9(3): p. 228-31.

13.

Jump up Rihawi, S., M. Frentz, and N.F. Schrage, Emergency treatment of eye burns:
which rinsing solution should we choose? Graefe's archive for clinical and experimental
ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie,
2006. 244(7): p. 845-54.

14.

Jump up to:14.0 14.1 Dohlman, C.H., F. Cade, and R. Pfister, Chemical burns to the eye: paradigm
shifts in treatment. Cornea, 2011. 30(6): p. 613-4.

15.

Jump up Ikeda, N., et al., Alkali burns of the eye: effect of immediate copious irrigation with
tap water on their severity. Ophthalmologica. Journal international d'ophtalmologie.
International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 2006. 220(4): p. 225-8.

16.

Jump up Donshik, P.C., et al., Effect of topical corticosteroids on ulceration in alkali-burned


corneas. Archives of ophthalmology, 1978. 96(11): p. 2117-20.

17.

Jump up Pfister, R.R., J.L. Haddox, and D. Yuille-Barr, The combined effect of
citrate/ascorbate treatment in alkali-injured rabbit eyes. Cornea, 1991. 10(2): p. 100-4.

18.

Jump up Gabardi, S., K. Munz, and C. Ulbricht, A review of dietary supplement-induced


renal dysfunction. Clinical journal of the American Society of Nephrology : CJASN, 2007. 2(4):
p. 757-65.

19.

Jump up Ralph, R.A., Tetracyclines and the treatment of corneal stromal ulceration: a
review. Cornea, 2000. 19(3): p. 274-7.

20.

Jump up Smith, V.A. and S.D. Cook, Doxycycline-a role in ocular surface repair. The British
journal of ophthalmology, 2004. 88(5): p. 619-25.

21.

Jump up Matsuda, H. and G.K. Smelser, Epithelium and stroma in alkali-burned corneas.
Archives of ophthalmology, 1973. 89(5): p. 396-401.

22.

Jump up Haddox, J.L., R.R. Pfister, and S.E. Slaughter, An excess of topical calcium and
magnesium reverses the therapeutic effect of citrate on the development of corneal ulcers after
alkali injury. Cornea, 1996. 15(2): p. 191-5.

23.

Jump up Pfister, R.R., J.L. Haddox, and C.I. Sommers, Effect of synthetic
metalloproteinase inhibitor or citrate on neutrophil chemotaxis and the respiratory burst.
Investigative ophthalmology & visual science,
1997. 38(7): p. 1340-9.

24.

Jump up Gross, J., et al., Inhibition of tumor growth, vascularization, and collagenolysis in
the rabbit cornea by medroxyprogesterone. Proceedings of the National Academy of Sciences
of the United States of America, 1981. 78(2): p. 1176-80.

25.

Jump up Panda, A., et al., Topical autologous platelet-rich plasma eyedrops for acute
corneal chemical injury. Cornea, 2012. 31(9): p. 989-93.

26.

Jump up Kuckelkorn, R., N. Schrage, and M. Reim, Treatment of severe eye burns by
tenonplasty. Lancet, 1995. 345(8950): p. 657-8.

27.

Jump up Shafto, C.M., A simple method of inserting amniotic membrane grafts into the
conjunctival sac. The British journal of ophthalmology, 1950. 34(7): p. 445-6.

28.

Jump up Baum, J., Thygeson lecture. Amniotic membrane transplantation: why is it


effective? Cornea, 2002. 21(4): p. 339-41.

29.

Jump up Tseng, S.C., et al., Intraoperative mitomycin C and amniotic membrane


transplantation for fornix reconstruction in severe cicatricial ocular surface diseases.
Ophthalmology, 2005. 112(5): p. 896-903.

30.

Jump up Hopkinson, A., et al., Amniotic membrane for ocular surface reconstruction: donor
variations and the effect of handling on TGF-beta content. Investigative ophthalmology
& visual science, 2006. 47(10): p.
4316-22.

31.

Jump up Gicquel, J.J., et al., Epidermal growth factor variations in amniotic membrane
used for ex vivo tissue constructs. Tissue engineering. Part A, 2009. 15(8): p. 1919-1927.

32.

Jump up Ueta, M., et al., Immunosuppressive properties of human amniotic membrane for
mixed lymphocyte reaction. Clinical and experimental immunology, 2002. 129(3): p. 464-70.

33.

Jump up Hao, Y., et al., Identification of antiangiogenic and antiinflammatory proteins in


human amniotic membrane. Cornea, 2000. 19(3): p. 348-52.

34.

Jump up Li, W., et al., Amniotic membrane induces apoptosis of interferon-gamma


activated macrophages in vitro. Experimental eye research, 2006. 82(2): p. 282-92.

35.

Jump up Kheirkhah, A., et al., Temporary sutureless amniotic membrane patch for acute
alkaline burns. Archives of ophthalmology, 2008. 126(8): p. 1059-66.

36.

Jump up Tandon, R., et al., Amniotic membrane transplantation as an adjunct to medical


therapy in acute ocular burns. The British journal of ophthalmology, 2011. 95(2): p. 199-204.

37.

Jump up to:37.0 37.1 Huang, T., et al., Limbal from living-related donors to treat partial limbal
deficiency secondary to ocular chemical burns. Archives of ophthalmology, 2011. 129(10): p.
1267-73.

38.

Jump up Morgan, S. and A. Murray, Limbal autotransplantation in the acute and chronic
phases of severe chemical injuries. Eye, 1996. 10 ( Pt 3): p. 349-54.

39.

Jump up Tsai, R.J. and S.C. Tseng, Human allograft limbal transplantation for corneal
surface reconstruction. Cornea, 1994. 13(5): p. 389-400

40.

Jump up Samson, C.M., et al., Limbal stem cell transplantation in chronic inflammatory eye
disease. Ophthalmology, 2002. 109(5): p. 862-8.

41.

Jump up Liang, L., H. Sheha, and S.C. Tseng, Long-term outcomes of keratolimbal
allograft for total limbal stem cell deficiency using combined immunosuppressive agents and
correction of ocular surface deficits. Archives of ophthalmology, 2009. 127(11): p. 1428-34.

42.

Jump up Ma, D.H., et al., Transplantation of cultivated oral mucosal epithelial cells for
severe corneal burn. Eye, 2009. 23(6): p. 1442-50.

43.

Jump up Nakamura, T., et al., Transplantation of cultivated autologous oral mucosal


epithelial cells in patients with severe ocular surface disorders. The British journal of
ophthalmology, 2004. 88(10): p. 1280-4.

44.

Jump up Khan, B., E.J. Dudenhoefer, and C.H. Dohlman, Keratoprosthesis: an update.
Current opinion in ophthalmology, 2001. 12(4): p. 282-7.

45.

Jump up Hemmati, H.D. and KA Colby , Treating acute chemical injuries of the cornea.
Eyenet, October 2012: p. 43-45.

46.

Jump up Paterson, C.A. and R.R. Pfister, Intraocular pressure changes after alkali burns.
Archives of ophthalmology, 1974. 91(3): p. 211-8.

47.

Jump up Le, Q., et al., Vision-related quality of life in patients with ocular chemical burns.
Investigative ophthalmology & visual science, 2011. 52(12): p. 8951-6.

48.

Jump up Kheirkhah, A., et al., A Combined Approach of Amniotic Membrane and Oral
Mucosa Transplantation for Fornix Reconstruction in Severe Symblepharon. Cornea, 2012.

49.

Jump up Tuft, S.J. and A.J. Shortt, Surgical rehabilitation following severe ocular burns.
Eye, 2009. 23(10): p. 1966-71.

This page was last modified on September 30, 2014, at 11:16.

This page has been accessed 81,814 times.